Bora CDMO Bora CDMO

X

CAS 498-02-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
4hydroxy-3-methoxyacetophenone
Also known as: Apocynin, 498-02-2, 4'-hydroxy-3'-methoxyacetophenone, 1-(4-hydroxy-3-methoxyphenyl)ethanone, Acetoguaiacone, Apocynine
Molecular Formula
C9H10O3
Molecular Weight
166.17  g/mol
InChI Key
DFYRUELUNQRZTB-UHFFFAOYSA-N
FDA UNII
B6J7B9UDTR

Acetovanillone is a metabolite found in or produced by Saccharomyces cerevisiae.
1 2D Structure

4hydroxy-3-methoxyacetophenone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(4-hydroxy-3-methoxyphenyl)ethanone
2.1.2 InChI
InChI=1S/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H3
2.1.3 InChI Key
DFYRUELUNQRZTB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)C1=CC(=C(C=C1)O)OC
2.2 Other Identifiers
2.2.1 UNII
B6J7B9UDTR
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4'-hydroxy-3'-methoxyacetophenone

2. 4-hydroxy-3-methoxyacetophenone

3. Apocynin

4. Apocynine

2.3.2 Depositor-Supplied Synonyms

1. Apocynin

2. 498-02-2

3. 4'-hydroxy-3'-methoxyacetophenone

4. 1-(4-hydroxy-3-methoxyphenyl)ethanone

5. Acetoguaiacone

6. Apocynine

7. Acetoguaiacon

8. 4-acetyl-2-methoxyphenol

9. Acetovanilone

10. Acetovanyllon

11. 4-hydroxy-3-methoxyacetophenone

12. Ethanone, 1-(4-hydroxy-3-methoxyphenyl)-

13. 3-methoxy-4-hydroxyacetophenone

14. 1-(4-hydroxy-3-methoxyphenyl)ethan-1-one

15. 4-hydroxy-3-methoxyphenyl Methyl Ketone

16. Acetophenone, 4'-hydroxy-3'-methoxy-

17. Nsc 209524

18. 3-metoksy-4-hydroksyacetofenon

19. 2-methoxy-4-acetylphenol

20. Acetovanillon

21. B6j7b9udtr

22. Nsc-209524

23. Chebi:2781

24. 1-(4-hydroxy-3-methoxy-phenyl)-ethanone

25. Wln: 1vr Dq Co1

26. Einecs 207-854-5

27. Brn 0637373

28. Ccris 7285

29. Unii-b6j7b9udtr

30. 3-metoksy-4-hydroksyacetofenon [polish]

31. Ai3-15892

32. 4-acetylguaiacol

33. 1-(4-hydroxy-3-methoxy-phenyl)ethanone

34. Apocynin [mi]

35. Apocynin (acetovanillone)

36. Bmse000584

37. Bmse010031

38. Phenol, 4-acetyl-2-methoxy

39. 4-08-00-01814 (beilstein Handbook Reference)

40. Mls001304972

41. Schembl109514

42. 4-hydroxy3-methoxyacetophenone

43. 4hydroxy-3-methoxyacetophenone

44. Acetovanillone, >=98%, Fg

45. Chembl346919

46. Dtxsid7060097

47. 4-hydroxy -3-methoxyacetophenone

48. Nsc2146

49. Acetovanillone, Analytical Standard

50. Hms3651h03

51. Zinc162515

52. 3'-methoxy-4'-hydroxyacetophenone

53. Hy-n0088

54. Nsc 2146

55. Nsc-2146

56. Str03975

57. 3-methyl Methcathinone Hydrochloride

58. Bbl009710

59. Mfcd00008747

60. Nsc209524

61. S2425

62. Stl141075

63. Zinc00162515

64. Akos000120562

65. 4-hydroxy-3-methoxyphenyl Methyl Keton

66. Ccg-266327

67. Cs-5647

68. Db12618

69. Fs-3673

70. 1-(4-hydroxy-3-methoxyphenyl)-ethanone

71. Ncgc00247065-01

72. 4'-hydroxy-3'-methoxyacetophenone, 98%

73. Ac-29981

74. Smr000752909

75. 1-(4-hydroxy-3-methoxyphenyl)-1-ethanone

76. Am20090774

77. Ft-0618638

78. H0261

79. Sw219526-1

80. D70564

81. Aa-504/20839006

82. Q414754

83. Q-200477

84. Acetophenone,4-hydroxy,3-methoxy Acetovanillon

85. F2191-0004

86. 16522-48-8

87. I75

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 166.17 g/mol
Molecular Formula C9H10O3
XLogP30.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass166.062994177 g/mol
Monoisotopic Mass166.062994177 g/mol
Topological Polar Surface Area46.5 Ų
Heavy Atom Count12
Formal Charge0
Complexity167
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antioxidants

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Flag China
Digital Content Digital Content
URL Supplier Web Content
22246-18-0
Brexpiprazole
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
70500-72-0
Brexpiprazole
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
5118-13-8
Brexpiprazole
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
66490-33-3
Brexpiprazole
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
913614-18-3
Brexpiprazole
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY